| Dr Alberto Jose Romero, MD, | |
|
4343 Fairmont Pkwy, Pasadena, TX 77504-3305 | |
| (281) 991-0444 | |
| (713) 946-7442 |
| Full Name | Dr Alberto Jose Romero |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 4343 Fairmont Pkwy, Pasadena, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023002292 | NPI | - | NPPES |
| 145830901 | Medicaid | TX | |
| 8B3010 | Other | TX | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K3839 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hca Houston Healthcare Southeast | Pasadena, TX | Hospital |
| Entity Name | Baycenter Family Physician, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679759245 PECOS PAC ID: 3870787187 Enrollment ID: O20101101000686 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,729,772 which covers a method for using an implantable neuromodulation system in the treatment of urinary incontinence by neuromodulation or stimulation of the tibial nerve. The neuromodulation system includes a portable, external transmitter and a receiver implanted subcutaneously in the leg or ankle near the tibial nerve.
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
Noting "several federal agencies released new details about the impact of sequestration on their budgets and programs," the Global Health Technologies Coalition's Communications Officer Kim Lufkin writes in the group's "Breakthroughs" blog.
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state and killing more than 600,000 people each year in the U.S. alone.
Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alberto Jose Romero, MD, 4515 Amble Oak Ct, Houston, TX 77059-6451 Ph: (281) 635-1495 | Dr Alberto Jose Romero, MD, 4343 Fairmont Pkwy, Pasadena, TX 77504-3305 Ph: (281) 991-0444 |
News Archive
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,729,772 which covers a method for using an implantable neuromodulation system in the treatment of urinary incontinence by neuromodulation or stimulation of the tibial nerve. The neuromodulation system includes a portable, external transmitter and a receiver implanted subcutaneously in the leg or ankle near the tibial nerve.
Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.
Noting "several federal agencies released new details about the impact of sequestration on their budgets and programs," the Global Health Technologies Coalition's Communications Officer Kim Lufkin writes in the group's "Breakthroughs" blog.
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other state and killing more than 600,000 people each year in the U.S. alone.
Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.
› Verified 1 days ago
Mr. Deepak Pattanaik, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5030 Crenshaw Rd, Suite 120, Pasadena, TX 77505 Phone: 713-943-8229 Fax: 713-943-9608 | |
Dr. Ruben Almaguer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3351 Plainview St, Suite A-7, Pasadena, TX 77504 Phone: 713-943-3582 Fax: 713-910-4440 | |
Hector Cantu, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6002 Fairmont Pkwy, Pasadena, TX 77505 Phone: 713-359-2100 Fax: 713-359-2100 | |
Mr. John D Kirkwood, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4001 Preston Ave, Suite 110, Pasadena, TX 77505 Phone: 281-249-2251 Fax: 281-249-2282 | |
Louise Cooper Henson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 908 Southmore Ave, Suite 100, Pasadena, TX 77502 Phone: 713-554-1091 Fax: 713-554-1096 | |
Dr. Rashmi Rode, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 927 E Shaw St, Pasadena, TX 77506 Phone: 713-982-5900 |